Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 340

1.

Activation of Toll-like receptor 2 impairs hypoxic pulmonary vasoconstriction in mice.

Petersen B, Bloch KD, Ichinose F, Shin HS, Shigematsu M, Bagchi A, Zapol WM, Hellman J.

Am J Physiol Lung Cell Mol Physiol. 2008 Feb;294(2):L300-8. Epub 2007 Nov 30.

2.

Reactive oxygen species scavengers attenuate endotoxin-induced impairment of hypoxic pulmonary vasoconstriction in mice.

Baboolal HA, Ichinose F, Ullrich R, Kawai N, Bloch KD, Zapol WM.

Anesthesiology. 2002 Nov;97(5):1227-33.

PMID:
12411809
3.

Congenital NOS2 deficiency prevents impairment of hypoxic pulmonary vasoconstriction in murine ventilator-induced lung injury.

Liu R, Hotta Y, Graveline AR, Evgenov OV, Buys ES, Bloch KD, Ichinose F, Zapol WM.

Am J Physiol Lung Cell Mol Physiol. 2007 Nov;293(5):L1300-5. Epub 2007 Aug 24.

4.

Attenuation of hypoxic pulmonary vasoconstriction by endotoxemia requires 5-lipoxygenase in mice.

Ichinose F, Zapol WM, Sapirstein A, Ullrich R, Tager AM, Coggins K, Jones R, Bloch KD.

Circ Res. 2001 Apr 27;88(8):832-8.

5.

Hypoxic pulmonary blood flow redistribution and arterial oxygenation in endotoxin-challenged NOS2-deficient mice.

Ullrich R, Bloch KD, Ichinose F, Steudel W, Zapol WM.

J Clin Invest. 1999 Nov;104(10):1421-9.

6.

Role of endogenous nitric oxide in endotoxin-induced alteration of hypoxic pulmonary vasoconstriction in mice.

Spöhr F, Cornelissen AJ, Busch C, Gebhard MM, Motsch J, Martin EO, Weimann J.

Am J Physiol Heart Circ Physiol. 2005 Aug;289(2):H823-31. Epub 2005 Mar 18.

7.

4-Aminopyridine restores impaired hypoxic pulmonary vasoconstriction in endotoxemic mice.

Spöhr F, Busch CJ, Reich C, Motsch J, Gebhard MM, Kuebler WM, Bloch KD, Weimann J.

Anesthesiology. 2007 Oct;107(4):597-604.

PMID:
17893456
8.

Selective inhibition of guanylate cyclase prevents impairment of hypoxic pulmonary vasoconstriction in endotoxemic mice.

Spohr F, Busch CJ, Teschendorf P, Weimann J.

J Physiol Pharmacol. 2009 Jun;60(2):107-12.

9.

Cysteinyl leukotrienes impair hypoxic pulmonary vasoconstriction in endotoxemic mice.

Petersen B, Austen KF, Bloch KD, Hotta Y, Ichinose F, Kanaoka Y, Zapol WM.

Anesthesiology. 2011 Oct;115(4):804-11. doi: 10.1097/ALN.0b013e31822e94bd.

10.

Genome-wide transcriptional profiling of mononuclear phagocytes recruited to mouse lungs in response to alveolar challenge with the TLR2 agonist Pam3CSK4.

Cabanski M, Wilhelm J, Zaslona Z, Steinmüller M, Fink L, Seeger W, Lohmeyer J.

Am J Physiol Lung Cell Mol Physiol. 2009 Oct;297(4):L608-18. doi: 10.1152/ajplung.90433.2008. Epub 2009 Jul 17.

11.

NOS3 deficiency augments hypoxic pulmonary vasoconstriction and enhances systemic oxygenation during one-lung ventilation in mice.

Liu R, Evgenov OV, Ichinose F.

J Appl Physiol (1985). 2005 Feb;98(2):748-52. Epub 2004 Oct 1.

12.

Low-tidal-volume mechanical ventilation induces a toll-like receptor 4-dependent inflammatory response in healthy mice.

Vaneker M, Joosten LA, Heunks LM, Snijdelaar DG, Halbertsma FJ, van Egmond J, Netea MG, van der Hoeven JG, Scheffer GJ.

Anesthesiology. 2008 Sep;109(3):465-72. doi: 10.1097/ALN.0b013e318182aef1.

PMID:
18719444
13.

Role of Toll-like receptor 4 for the pathogenesis of acute lung injury in Gram-negative sepsis.

Baumgarten G, Knuefermann P, Wrigge H, Putensen C, Stapel H, Fink K, Meyer R, Hoeft A, Grohé C.

Eur J Anaesthesiol. 2006 Dec;23(12):1041-8. Epub 2006 Jul 12.

PMID:
16836770
14.

A selective inducible NOS dimerization inhibitor prevents systemic, cardiac, and pulmonary hemodynamic dysfunction in endotoxemic mice.

Ichinose F, Hataishi R, Wu JC, Kawai N, Rodrigues AC, Mallari C, Post JM, Parkinson JF, Picard MH, Bloch KD, Zapol WM.

Am J Physiol Heart Circ Physiol. 2003 Dec;285(6):H2524-30. Epub 2003 Aug 7.

15.

[Hypoxic pulmonary vasoconstriction].

Theissen IL, Meissner A.

Anaesthesist. 1996 Jul;45(7):643-52. Review. German.

PMID:
8765866
16.

Attenuated pathogenesis of polymicrobial peritonitis in mice after TLR2 agonist pre-treatment involves ST2 up-regulation.

Feterowski C, Novotny A, Kaiser-Moore S, Mühlradt PF, Rossmann-Bloeck T, Rump M, Holzmann B, Weighardt H.

Int Immunol. 2005 Aug;17(8):1035-46. Epub 2005 Jul 6.

17.

Basic features of hypoxic pulmonary vasoconstriction in mice.

Weissmann N, Akkayagil E, Quanz K, Schermuly RT, Ghofrani HA, Fink L, Hänze J, Rose F, Seeger W, Grimminger F.

Respir Physiol Neurobiol. 2004 Jan 15;139(2):191-202.

PMID:
15123002
18.

Priming by lipopolysaccharide exaggerates acute lung injury and mortality in responses to peptidoglycan through up-regulation of Toll-like receptor-2 expression in mice.

Matsuda N, Yamazaki H, Takano K, Matsui K, Takano Y, Kemmotsu O, Hattori Y.

Biochem Pharmacol. 2008 Mar 1;75(5):1065-75. Epub 2007 Nov 9.

PMID:
18096135
19.

Pulmonary vasoconstriction during regional nitric oxide inhalation: evidence of a blood-borne regulator of nitric oxide synthase activity.

Hambraeus-Jonzon K, Chen L, Fredén F, Wiklund P, Hedenstierna G.

Anesthesiology. 2001 Jul;95(1):102-12.

PMID:
11465547
20.

Inhibition of hypoxic pulmonary vasoconstriction by carbon monoxide in dogs.

Vassalli F, Pierre S, Julien V, Bouckaert Y, Brimioulle S, Naeije R.

Crit Care Med. 2001 Feb;29(2):359-66.

PMID:
11246317
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk